Chronic recurrent multifocal osteomyelitis (CRMO) research hub

POMREP - Efficacy and safety of zoledronate versus placebo on pain at week 12 in pediatric patients with chronic recurrent multifocal osteomyelitis resistant to non-steroidal anti-inflammatory drug

This study looks at how well a medicine called zoledronate works for children with a bone condition called CRMO. We want to see if it helps reduce pain and if it's safe, compared to a dummy medicine.